Companies/US/DLB

DOLBY LABORATORIES, INC.

Income flow

Annual
DLB 10-K Income StatementPeriod 2025-09-26Source 10-K
Total Licensing Revenue$675MLicensing Brodcast Revenue$232MLicensing Mobile Revenue$145MLicensing Other Revenue$134MLicensing PCRevenue$82MLicensing CERevenue$81MRevenue$1B+6% Y/YGross profit$1B+5% Y/YCost of revenue$160MOperating profit$265M+3% Y/YOperating expenses$924MNet profit$255M-3% Y/YTax$47MR&D & other$638MSG&A$287M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-09-26 · 10-K · USD
By activity
By activity$2.5B
  • Total Licensing Revenue$1.2B50.0%
  • Licensing Brodcast Revenue$428M17.2%
  • Licensing Mobile Revenue$269M10.8%
  • Licensing Other Revenue$248M9.9%
  • Licensing PCRevenue$152M6.1%
  • Licensing CERevenue$151M6.0%
By geography
By geography$1.3B
  • Non-US$852M63.2%
  • United States$497M36.8%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).2.47%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.1.49%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).1.44PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.60.0%Shares outTotal shares currently outstanding (issued and not retired).59.4MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).58.8M
Dividend calendar
Ex-dividend
2026-08-11
Pay date
2026-08-19
Last cash
0.36 · 2026-08-11

Valuation

Trailing PE 27.0 (2025-09-26)PE trend

Fiscal PE2

PeriodEPSClosePE
2025-09-262.6270.7527.0
2024-09-272.6972.6627.0

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.